New treatment approach improves recurrence-free survival in early breast cancer patie

[News]

A new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer returning, according to a new study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators.

More... (https://www.news-medical.net/news/20240320/New-treatment-approach-improves-recurrence-free-survival-in-early-breast-cancer-patients.aspx)